<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en" dir="ltr">
  <head>
    <meta http-equiv="Content-Type" content="text/html; charset=UTF-8" />
    		<meta name="keywords" content="Alexander Shulgin,1925,2006,2C* family,2C-B,2C-I,2C-T-2,2C-T-7,Ann Shulgin,Berkeley, California,Bioassay" />
		<link rel="shortcut icon" href="/favicon.ico" />
		<link rel="search" type="application/opensearchdescription+xml" href="/w/opensearch_desc.php" title="Wikipedia (English)" />
		<link rel="copyright" href="../../../COPYING.html" />
    <title>Alexander Shulgin - Wikipedia, the free encyclopedia</title>
    <style type="text/css">/*<![CDATA[*/ @import "../../../skins/htmldump/main.css"; /*]]>*/</style>
    <link rel="stylesheet" type="text/css" media="print" href="../../../skins/common/commonPrint.css" />
    <!--[if lt IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE50Fixes.css";</style><![endif]-->
    <!--[if IE 5.5000]><style type="text/css">@import "../../../skins/monobook/IE55Fixes.css";</style><![endif]-->
    <!--[if IE 6]><style type="text/css">@import "../../../skins/monobook/IE60Fixes.css";</style><![endif]-->
    <!--[if IE]><script type="text/javascript" src="../../../skins/common/IEFixes.js"></script>
    <meta http-equiv="imagetoolbar" content="no" /><![endif]-->
    <script type="text/javascript" src="../../../skins/common/wikibits.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/md5.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/utf8.js"></script>
    <script type="text/javascript" src="../../../skins/htmldump/lookup.js"></script>
    <script type="text/javascript" src="../../../raw/gen.js"></script>        <style type="text/css">/*<![CDATA[*/
@import "../../../raw/MediaWiki%7ECommon.css";
@import "../../../raw/MediaWiki%7EMonobook.css";
@import "../../../raw/gen.css";
/*]]>*/</style>          </head>
  <body
    class="ns-0">
    <div id="globalWrapper">
      <div id="column-content">
	<div id="content">
	  <a name="top" id="contentTop"></a>
	        <h1 class="firstHeading">Alexander Shulgin</h1>
	  <div id="bodyContent">
	    <h3 id="siteSub">From Wikipedia, the free encyclopedia</h3>
	    <div id="contentSub"></div>
	    	    <div class="usermessage">You have <a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">new messages</a> (<a href="../../../1/2/7/User_talk%7E127.0.0.1.html" title="User talk:127.0.0.1">last change</a>).</div>	    <!-- start content -->
	    <div class="dablink"><i>For other uses, see <a href="../../../s/h/u/Shulgin_Alexander_a990.html" title="Shulgin Alexander">Shulgin Alexander</a>.</i></div>
<div class="thumb tright">
<div class="thumbinner" style="width:202px;"><a href="../../../s/h/u/Image%7EShulgin.jpg_5053.html" class="internal" title="Alexander and Ann Shulgin, in a photo from their book TiHKAL, c. 1997."><img src="../../../upload/thumb/9/92/Shulgin.jpg/200px-Shulgin.jpg" alt="Alexander and Ann Shulgin, in a photo from their book TiHKAL, c. 1997." width="200" height="200" longdesc="../../../s/h/u/Image%7EShulgin.jpg_5053.html" class="thumbimage" /></a>
<div class="thumbcaption">
<div class="magnify" style="float:right"><a href="../../../s/h/u/Image%7EShulgin.jpg_5053.html" class="internal" title="Enlarge"><img src="../../../skins/common/images/magnify-clip.png" width="15" height="11" alt="" /></a></div>
Alexander and <a href="../../../a/n/n/Ann_Shulgin_1af3.html" title="Ann Shulgin">Ann</a> Shulgin, in a photo from their book <a href="../../../t/i/h/TiHKAL_8116.html" title="TiHKAL">TiHKAL</a>, c. 1997.</div>
</div>
</div>
<p><b>Alexander "Shura" Shulgin</b> (born <a href="../../../j/u/n/June_17.html" title="June 17">June 17</a>, <a href="../../../1/9/2/1925.html" title="1925">1925</a> in <a href="../../../b/e/r/Berkeley%2C_California_6eb4.html" title="Berkeley, California">Berkeley</a>, <a href="../../../c/a/l/California.html" title="California">California</a>) is an <a href="../../../u/n/i/United_States_09d4.html" title="United States">American</a> <a href="../../../p/h/a/Pharmacologist.html" title="Pharmacologist">pharmacologist</a>, <a href="../../../c/h/e/Chemist.html" title="Chemist">chemist</a> and <a href="../../../p/s/y/Psychoactive_drug.html" title="Psychoactive drug">drug</a> developer of Russian descent.</p>
<p>Shulgin is credited with the popularizing of <a href="../../../m/e/t/Methylenedioxymethamphetamine.html" title="Methylenedioxymethamphetamine">MDMA</a> in the late 1970s and early 1980s, especially for psychopharmaceutical use and the treatment of depression and <a href="../../../p/o/s/Post-traumatic_stress_disorder.html" title="Post-traumatic stress disorder">Post-traumatic stress disorder</a>. In subsequent years, Shulgin discovered, synthesized, and <a href="../../../b/i/o/Bioassay.html" title="Bioassay">bioassayed</a> over 230 psychoactive compounds. In 1991 and 1997, he and his wife <a href="../../../a/n/n/Ann_Shulgin_1af3.html" title="Ann Shulgin">Ann Shulgin</a> authored the books <i><a href="../../../p/i/h/PiHKAL_f281.html" title="PiHKAL">PiHKAL</a></i> and <i><a href="../../../t/i/h/TiHKAL_8116.html" title="TiHKAL">TiHKAL</a></i> on the topic of <a href="../../../p/s/y/Psychoactive_drugs.html" title="Psychoactive drugs">psychoactive drugs</a>. Shulgin discovered many noteworthy <a href="../../../p/h/e/Phenethylamines.html" title="Phenethylamines">phenethylamines</a> including the <a href="../../../2/c/2A/2C__family_5eef.html" title="2C* family">2C* family</a> of which <a href="../../../2/c/-/2C-T-2_83ad.html" title="2C-T-2">2C-T-2</a>, <a href="../../../2/c/-/2C-T-7_2d3e.html" title="2C-T-7">2C-T-7</a>, <a href="../../../2/c/-/2C-I_41c4.html" title="2C-I">2C-I</a>, and <a href="../../../2/c/-/2C-B_de93.html" title="2C-B">2C-B</a> are most well known. Additionally, Shulgin performed seminal work into the descriptive synthesis of compounds based on the organic compound <a href="../../../t/r/y/Tryptamine.html" title="Tryptamine">tryptamine</a>.</p>
<p>He is currently continuing his work at home in <a href="../../../l/a/f/Lafayette%2C_California_4fa6.html" title="Lafayette, California">Lafayette</a>, <a href="../../../c/a/l/California.html" title="California">CA</a>, and is writing a new comprehensive psychedelic drug index.</p>
<table id="toc" class="toc" summary="Contents">
<tr>
<td>
<div id="toctitle">
<h2>Contents</h2>
</div>
<ul>
<li class="toclevel-1"><a href="#Early_career"><span class="tocnumber">1</span> <span class="toctext">Early career</span></a></li>
<li class="toclevel-1"><a href="#Independent_research"><span class="tocnumber">2</span> <span class="toctext">Independent research</span></a></li>
<li class="toclevel-1"><a href="#Bibliography"><span class="tocnumber">3</span> <span class="toctext">Bibliography</span></a>
<ul>
<li class="toclevel-2"><a href="#Books"><span class="tocnumber">3.1</span> <span class="toctext">Books</span></a></li>
<li class="toclevel-2"><a href="#Other_notable_publications"><span class="tocnumber">3.2</span> <span class="toctext">Other notable publications</span></a></li>
</ul>
</li>
<li class="toclevel-1"><a href="#Notes"><span class="tocnumber">4</span> <span class="toctext">Notes</span></a></li>
<li class="toclevel-1"><a href="#External_links"><span class="tocnumber">5</span> <span class="toctext">External links</span></a></li>
</ul>
</td>
</tr>
</table>
<p><script type="text/javascript">
//<![CDATA[
 if (window.showTocToggle) { var tocShowText = "show"; var tocHideText = "hide"; showTocToggle(); } 
//]]>
</script><a name="Early_career" id="Early_career"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/e/Alexander_Shulgin_ff31.html" title="Edit section: Early career">edit</a>]</span> <span class="mw-headline">Early career</span></h2>
<p>Shulgin began studying organic chemistry as a <a href="../../../h/a/r/Harvard_University_9346.html" title="Harvard University">Harvard University</a> scholarship student. At the age of 19, he dropped out of school, and joined the <a href="../../../u/2E/s/U.S._Navy_1b88.html" title="U.S. Navy">U.S. Navy</a>, where he eventually became interested in <a href="../../../p/h/a/Pharmacology.html" title="Pharmacology">pharmacology</a>.<sup id="_ref-nyt_0" class="reference"><a href="#_note-nyt" title="">[1]</a></sup> After serving in the Navy, he returned to <a href="../../../b/e/r/Berkeley%2C_California_6eb4.html" title="Berkeley, California">Berkeley</a>, <a href="../../../c/a/l/California.html" title="California">California</a>, and in 1954, earned his Ph.D. in <a href="../../../b/i/o/Biochemistry.html" title="Biochemistry">Biochemistry</a> from the <a href="../../../u/n/i/University_of_California%2C_Berkeley_70e2.html" title="University of California, Berkeley">University of California, Berkeley</a>. Through the late 50's, Shulgin completed post-doctoral work in the fields of <a href="../../../p/s/y/Psychiatry.html" title="Psychiatry">psychiatry</a> and <a href="../../../p/h/a/Pharmacology.html" title="Pharmacology">pharmacology</a> at <a href="../../../u/n/i/University_of_California%2C_San_Francisco_0ec6.html" title="University of California, San Francisco">University of California, San Francisco</a>. After working at BioRad Laboratories as a research director for a brief period, he began work at <a href="../../../d/o/w/Dow_Chemical_Company_f82b.html" title="Dow Chemical Company">Dow Chemical Company</a> as a senior research chemist.<sup id="_ref-nyt_1" class="reference"><a href="#_note-nyt" title="">[1]</a></sup></p>
<p>It was at this time that he experienced a series of psychedelic experiences that helped to shape his further goals and research, beginning with an experience with <a href="../../../m/e/s/Mescaline.html" title="Mescaline">mescaline</a>.<sup id="_ref-lat_0" class="reference"><a href="#_note-lat" title="">[2]</a></sup></p>
<blockquote class="toccolours" style="float:none; padding: 10px 15px 10px 15px; display:table;">
<p>I first explored mescaline in the late '50s, Three-hundred-fifty to 400 milligrams. I learned there was a great deal inside me.</p>
<p style="text-align: right;">– <cite style="font-style:normal;">Alexander Shulgin, <i><a href="../../../l/a/_/LA_Times_c23e.html" title="LA Times">LA Times</a>, 1995<sup id="_ref-lat_1" class="reference"><a href="#_note-lat" title="">[2]</a></sup></i></cite></p>
</blockquote>
<p>He would later write that everything he saw and thought "had been brought about by a fraction of a gram of a white solid, but that in no way whatsoever could it be argued that these memories had been contained within the white solid... I understood that our entire universe is contained in the mind and the spirit. We may choose not to find access to it, we may even deny its existence, but it is indeed there inside us, and there are chemicals that can catalyze its availability."</p>
<p>Shulgin's professional activities continued to lean in the direction of psychopharmacology, furthered by his personal experiences with psychedelics, but he was able to do little independent research. His opportunity for further research came with his development of Zectran, the first biodegradeable pesticide, and a highly profitable product. Dow Chemical Company, in return for the valuable patent, gave Shulgin great freedom in his research. During this time, he patented drugs he created when Dow asked, and published findings on others in journals such as <a href="../../../n/a/t/Nature_%28journal%29.html" title="Nature (journal)">Nature</a> and <a href="../../../j/o/u/Journal_of_Organic_Chemistry_50bf.html" title="Journal of Organic Chemistry">Journal of Organic Chemistry</a>. Eventually, Dow Chemical requested that he no longer use their name on his publications.<sup id="_ref-nyt_2" class="reference"><a href="#_note-nyt" title="">[1]</a></sup></p>
<p>In 1965, Shulgin left Dow to pursue his own interests, and became a private consultant, also frequently teaching classes in the local universities and at the <a href="../../../s/a/n/San_Francisco_General_Hospital_2baa.html" title="San Francisco General Hospital">San Francisco General Hospital</a>. Through his friend Bob Sager, head of the U.S. <a href="../../../d/r/u/Drug_Enforcement_Agency_a3fe.html" title="Drug Enforcement Agency">DEA</a>'s Western Laboratories, Shulgin formed a relationship with the DEA and began holding pharmacology seminars for the agents, supplying the DEA with samples of various compounds, and occasionally serving as an expert witness in court. He also authored a definitive law enforcement reference book on controlled substances<sup id="_ref-0" class="reference"><a href="#_note-0" title="">[3]</a></sup> and received several awards from the DEA.</p>
<p><a name="Independent_research" id="Independent_research"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/e/Alexander_Shulgin_ff31.html" title="Edit section: Independent research">edit</a>]</span> <span class="mw-headline">Independent research</span></h2>
<p>Through his work with the DEA, Shulgin obtained a DEA <a href="../../../c/o/n/Controlled_Substances_Act_0a87.html" title="Controlled Substances Act">Schedule I</a> license, allowing him to possess and synthesize any otherwise illicit drug. Shulgin set up a chemical synthesis laboratory in a small building behind his house, which gave him a great deal of career autonomy. Shulgin used this freedom to synthesize and test the effects of <a href="../../../p/s/y/Psychoactive_drug.html" title="Psychoactive drug">psychoactive drugs</a>.</p>
<p>In 1967, Shulgin was introduced to <a href="../../../m/d/m/MDMA_8cbe.html" title="MDMA">MDMA</a> (ecstasy) by a student at <a href="../../../u/n/i/University_of_California%2C_San_Francisco_0ec6.html" title="University of California, San Francisco">University of California, San Francisco</a>. <a href="../../../m/d/m/MDMA_8cbe.html" title="MDMA">MDMA</a> had been synthesized and patented by <a href="../../../m/e/r/Merck.html" title="Merck">Merck</a> in 1912 as a byproduct of another synthesis, but was considered useless, and was never explored. Shulgin went on to develop a new synthesis method, and in 1976, introduced the chemical to Leo Zeff, a <a href="../../../p/s/y/Psychologist.html" title="Psychologist">psychologist</a> from <a href="../../../o/a/k/Oakland%2C_California_0bc0.html" title="Oakland, California">Oakland</a>, <a href="../../../c/a/l/California.html" title="California">California</a>. Zeff used the substance in his practice in small doses as an aid to talk therapy. Zeff introduced the substance to hundreds of psychologists around the nation, including <a href="../../../a/n/n/Ann_Shulgin_1af3.html" title="Ann Shulgin">Ann Shulgin</a>, whom Alexander Shulgin met in 1979, and married in 1981.<sup id="_ref-nyt_3" class="reference"><a href="#_note-nyt" title="">[1]</a></sup></p>
<p>After judicious self-experiments, Shulgin enlisted a small group of friends with whom he regularly tested his creations. They developed a systematic way of ranking the effects of the various drugs, known as the <a href="../../../s/h/u/Shulgin_Rating_Scale_7a4a.html" title="Shulgin Rating Scale">Shulgin Rating Scale</a>, with a vocabulary to describe the visual, auditory and physical sensations. He personally tested hundreds of drugs, mainly analogues of various <a href="../../../p/h/e/Phenethylamine.html" title="Phenethylamine">phenethylamines</a> (family containing <a href="../../../e/c/s/Ecstasy_%28drug%29.html" title="Ecstasy (drug)">MDMA</a>, and <a href="../../../m/e/s/Mescaline.html" title="Mescaline">mescaline</a>), and <a href="../../../t/r/y/Tryptamine.html" title="Tryptamine">tryptamines</a> (family containing <a href="../../../d/i/m/Dimethyltryptamine.html" title="Dimethyltryptamine">DMT</a> and <a href="../../../p/s/i/Psilocybin.html" title="Psilocybin">psilocybin</a>). There are a seemingly infinite number of slight chemical variations, all of which produce variations in effect--some pleasant and some unpleasant--and all of which are meticulously recorded in Shulgin's books.<sup id="_ref-nyt_4" class="reference"><a href="#_note-nyt" title="">[1]</a></sup></p>
<p>In 1994, two years after the publication of <i><a href="../../../p/i/h/PiHKAL_f281.html" title="PiHKAL">PiHKAL</a></i>, the DEA raided his lab; finding problems with his record keeping, the DEA requested that Shulgin turn over his license for violating the license's terms, and he was fined US$25,000 for possession of anonymous samples sent to him for quality testing. Two earlier, unannounced reviews during the 15 years in which Shulgin held his license, both before the publication of <i><a href="../../../p/i/h/PiHKAL_f281.html" title="PiHKAL">PiHKAL</a></i>, had failed to find any irregularities.<sup id="_ref-1" class="reference"><a href="#_note-1" title="">[4]</a></sup> Richard Meyer, spokesman for DEA's San Francisco Field Division, has stated that "It is our opinion that those books are pretty much cookbooks on how to make illegal drugs. Agents tell me that in clandestine labs that they have raided, they have found copies of those books," suggesting to many that the publication of <i><a href="../../../p/i/h/PiHKAL_f281.html" title="PiHKAL">PiHKAL</a></i> and the termination of Shulgin's license were related.<sup id="_ref-nyt_5" class="reference"><a href="#_note-nyt" title="">[1]</a></sup></p>
<p><a name="Bibliography" id="Bibliography"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/e/Alexander_Shulgin_ff31.html" title="Edit section: Bibliography">edit</a>]</span> <span class="mw-headline">Bibliography</span></h2>
<p><a name="Books" id="Books"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/e/Alexander_Shulgin_ff31.html" title="Edit section: Books">edit</a>]</span> <span class="mw-headline">Books</span></h3>
<ul>
<li>with Wendy Perry. <i>The Simple Plant Isoquinolines</i>. Berkeley: Transform Press, 2002. [<a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-9630096-2-1</a>]</li>
<li>with Ann Shulgin. "A New Vocabulary". In Robert Forte (ed.), <i>Entheogens and the Future of Religion</i>, Berkeley: Council on Spiritual Practices, 1997. [<a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 1-889725-01-3</a>]</li>
<li>with Ann Shulgin. <i><a href="../../../t/i/h/TiHKAL_8116.html" title="TiHKAL">Tihkal: The Continuation</a></i>. Berkeley: Transform Press, 1997. [<a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-9630096-9-9</a>]</li>
<li>with Ann Shulgin. <i><a href="../../../p/i/h/PiHKAL_f281.html" title="PiHKAL">Pihkal: A Chemical Love Story</a></i>. Berkeley: Transform Press, 1991. [<a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-9630096-0-5</a>]</li>
<li><i>Controlled Substances: Chemical &amp; Legal Guide to Federal Drug Laws</i>, Berkeley: Ronin Publishing, 1988. [<a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-914171-50-X</a>]</li>
</ul>
<p><a name="Other_notable_publications" id="Other_notable_publications"></a></p>
<h3><span class="editsection">[<a href="../../../a/l/e/Alexander_Shulgin_ff31.html" title="Edit section: Other notable publications">edit</a>]</span> <span class="mw-headline">Other notable publications</span></h3>
<ul>
<li>1963. "Psychotomimetic agents related to mescaline". Experientia 19: 127. 19</li>
<li>1963. "Composition of the myristicin fraction from oil of nutmeg". Nature 197: 379. 20</li>
<li>1963. "Concerning the pharmacology of nutmeg". Mind 1: 299-302. 23</li>
<li>1964. "3-methoxy-4,5-methylenedioxy amphetamine, a new psychotomimetic agent". Nature 201: 1120-1121. 29</li>
<li>1964. "Psychotomimetic amphetamines: methoxy 3,4-dialkoxyamphetamines". Experientia 20: 366. 30</li>
<li>1964. with H. O. Kerlinger. "Isolation of methoxyeugenol and trans-isoelemicin from oil of nutmeg". Naturwissenschaften 15: 360-361. 31</li>
<li>1965. "Synthesis of the trimethoxyphenylpropenes". Can. J. Chem. 43: 3437-3440. 43</li>
<li>1966. "Possible implication of myristicin as a psychotropic substance". Nature 210: 380-384. 45</li>
<li>1966. "The six trimethoxyphenylisopropylamines (trimethoxyamphetamines)". J. Med. Chem. 9: 445-446. 46</li>
<li>1966. with T. Sargent, and C. Naranjo. "Role of 3,4-dimethoxyphenethylamin in schizophrenia". Nature 212: 1606-1607. 48</li>
<li>1967. with T. Sargent, and C. Naranjo. "The chemistry and psychopharmacology of nutmeg and of several related phenylisopropylamines". In D. H. Efron [ed.]: Ethnopharmacologic search for psychoactive drugs. U. S. Dept. of H. E. W., Public Health Service Publication No. 1645. Pp. 202-214. Discussion: ibid. pp. 223-229. 49</li>
<li>1967. with T. Sargent. "Psychotropic phenylisopropylamines derived from apiole and <a href="../../../d/i/l/Dillapiole.html" title="Dillapiole">dillapiole</a>". Nature 215: 1494-1495. 50</li>
<li>1967. with Sargent, T. W., D. M. Israelstam, S. A. Landaw, and N. N. Finley. "A note concerning the fate of the 4-methoxyl group in 3,4-dimethoxyphenethylamine (DMPEA)". Biochem. Biophys. Res. Commun. 29: 126-130. 52</li>
<li>1967. with Naranjo, C. and T. Sargent. "Evaluation of 3,4-methylenedioxyamphetamine (MDA) as an adjunct to psychotherapy". Med. Pharmacol. Exp. 17: 359-364. 53</li>
<li>1968. "The ethyl homologs of 2,4,5-trimethoxyphenylisopropylamine". J. Med. Chem. 11: 186-187. 54</li>
<li>1969. with T. Sargent and C. Naranjo. "Structure activity relationships of one-ring psychotomimetics". Nature 221: 537-541. 57</li>
<li>1969. "Recent developments in cannabis chemistry". J. Psyched. Drugs 2: 15-29. 58</li>
<li>1969. "Psychotomimetic agents related to the catecholamines". J. Psyched. Drugs 2(2): 12-26. 59</li>
<li>1970. "Chemistry and structure-activity relationships of the psychotomimetics". In D. H. Efron [ed.]. "Psychotomimetic Drugs". Raven Press, New York. Pp. 21-41. 60</li>
<li>1970. "The mode of action of psychotomimetic drugs; some qualitative properties of the psychotomimetics". Neur. Res. Prog. Bull. 8: 72-78. 61</li>
<li>1970. "4-alkyl-dialkoxy-alpha-methyl-phenethylamines and their pharmacologically-acceptable salts". U. S. Patent 3,547,999, issued Dec. 15, 1970. 63</li>
<li>1971. with T. Sargent and C. Naranjo. "4-bromo-2,5-dimethoxyphenylisopropylamine, a new centrally active amphetamine analog". Pharmacology 5: 103-107. 64</li>
<li>1971. "Chemistry and sources". In S. S. Epstein [ed]. "Drugs of abuse: their genetic and other chronic nonpsychiatric hazards". The MIT Press, Cambridge, Mass. Pp 3-26. 65</li>
<li>1971. "Preliminary studies of the synthesis of nitrogen analogs of Delta1-THC". Acta Pharm. Suec. 8: 680-681. 66</li>
<li>1972. "Hallucinogens, CNS stimulants, and cannabis. In S. J. Mulé and H. Brill [eds.]: Chemical and biological aspects of drug dependence". CRC Press, Cleveland, Ohio. Pp. 163-175. 67</li>
<li>1973. "Stereospecific requirements for hallucinogenesis". J. Pharm. Pharmac. 25: 271-272. 68</li>
<li>1973. "Mescaline: the chemistry and pharmacology of its analogs". Lloydia 36: 46-58. 69</li>
<li>1973. "The narcotic pepper - the chemistry and pharmacology of Piper methysticum and related species". Bull. Narc. 25: 59-1974. "Le poivre stupéfiant - chemie et pharmacologie du Piper methysticum et des espéces apparentées". Bull. Stupéfiants 25: 61-77. 70</li>
<li>1973. with T. Sargent and C. Naranjo. "Animal pharmacology and human psychopharmacology of 3-methoxy-4,5-methylenedioxyphenylisopropylamine (MMDA)". Pharmacology 10: 12-18. 71</li>
<li>1974. with Kalbhen, D. A., T. Sargent, G. Braun, H. Stauffer, N. Kusubov, and M. L. Nohr. "Human pharmacodynamics of the psychodysleptic 4-bromo-2,5-dimethoxyphenylisopropylamine labelled with [82]Br". IRCS (Int. Res. Comm. Sys.) 2: 1091. 73</li>
<li>1975. with Sargent, T., D. A. Kalbhen, H. Stauffer, and N. Kusubov. "A potential new brain-scanning agent: 4-[77]Br-2,5-dimethoxyphenylisopropylamine (4-Br-DPIA)". J. Nucl. Med. 16: 243-245. 74</li>
<li>1975. with M. F. Carter. "Centrally active phenethylamines". Psychopharm. Commun. 1: 93-98. 75</li>
<li>1975. with Sargent, T., D. A. Kalbhen, G. Braun, H. Stauffer, and N. Kusubov. "In vivo human pharmacodynamics of the psychodysleptic 4-Br-2,5-dimethoxyphenylisopropylamine labelled with [82]Br or [77]Br". Neuropharmacology 14: 165-174. 76</li>
<li>1975. "The chemical catalysis of altered states of consciousness. Altered states of consciousness, current views and research problems". The drug abuse council, Washington, D. C. Pp. 123-134. 77</li>
<li>1975. "Drug use and anti-drug legislation". The PharmChem Newsletter 4 (#8). 79</li>
<li>1975. with D. C. Dyer. "Psychotomimetic phenylisopropylamines. 5. 4-alkyl-2,5-dimethoxyphenylisopropylamines". J. Med. Chem. 18: 1201-1204. 80</li>
<li>1975. with C. Helisten. "Differentiation of PCP, TCP, and a contaminating precursor PCC, by thin layer chromatography". Microgram 8: 171-172. 81</li>
<li>1975. with Helisten, C. "The detection of 1-piperidinodydlohexanecarbonitrile contamination in illicit preparations of 1-(1-phenylcyclohexyl)piperidine and 1-(1-(2-thienyl)cyclohexyl)piperidine". J. Chrom. 117: 232-235. 82</li>
<li>1976. "Psychotomimetic agents". In M. Gordon [ed.] "Psychopharmacological agents", Vol. 4. Academic Press, New York. Pp. 59-146. 83</li>
<li>1976. "Abuse of the term 'amphetamines'". Clin. Tox. 9: 351-352. 84</li>
<li>1976. "Profiles of psychedelic drugs. 1. DMT". J. Psychedelic Drugs 8: 167-168. 85</li>
<li>1976. "Profiles of psychedelic drugs. 2. TMA-2". J. Psychedelic Drugs 8: 169. 86</li>
<li>1976. with D. E. MacLean. "Illicit synthesis of phencyclidine (PCP) and several of its analogs". Clin. Tox. 9: 553-560. 87</li>
<li>1976. with Nichols, D. E. "Sulfur analogs of psychotomimetic amines". J. Pharm. Sci. 65: 1554-1556. 89</li>
<li>1976. with Sargent, T. and N. Kusubov. "Quantitative measurement of demethylation of [14]C-methoxyl labeled DMPEA and TMA-2 in rats". Psychopharm. Commun. 2: 199-206. 90</li>
<li>1976. with Standridge, R. T., H. G. Howell, J. A. Gylys, R. A. Partyka. "Phenylalkylamines with potential psychotherapeutic utility. 1. 2-amino-1-(2,5,-dimethoxy-4-methylphenyl)butane". J. Med. Chem. 19: 1400-1404. 91</li>
<li>1976. "Profiles of psychedelic drugs. 3. MMDA". J. Psychedelic Drugs 8: 331. 92</li>
<li>1977. "Profiles of psychedelic drugs. 4. Harmaline". J. Psychedelic Drugs 9: 79-80. 93</li>
<li>1977. "Profiles of psychedelic drugs. 5. STP". J. Psychedelic Drugs 9: 171-172. 94</li>
<li>1977. with Nichols, D. E., and D. C. Dyer. "Directional lipophilic character in a series of psychotomimetic phenethylamine derivatives". Life Sciences 21: 569-576. 95</li>
<li>1977. with Jacob, P. III, G. Anderson III, C. K. Meshul, and N. Castagnoli Jr. "Mononethylthio analogues of 1-(2,4,5-trimethoxyphenyl)2-aminopropane". J. Med. Chem. 20: 1235-1239. 96</li>
</ul>
<p><a name="Notes" id="Notes"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/e/Alexander_Shulgin_ff31.html" title="Edit section: Notes">edit</a>]</span> <span class="mw-headline">Notes</span></h2>
<div class="references-small">
<ol class="references">
<li id="_note-nyt">^ <a href="#_ref-nyt_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-nyt_1" title=""><sup><i><b>b</b></i></sup></a> <a href="#_ref-nyt_2" title=""><sup><i><b>c</b></i></sup></a> <a href="#_ref-nyt_3" title=""><sup><i><b>d</b></i></sup></a> <a href="#_ref-nyt_4" title=""><sup><i><b>e</b></i></sup></a> <a href="#_ref-nyt_5" title=""><sup><i><b>f</b></i></sup></a> Bennett, Drake. "<a href="http://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html" class="external text" title="http://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html" rel="nofollow">Dr. Ecstasy</a>", <i>New York Times Magazine</i>, <i><a href="../../../n/e/w/New_York_Times_d49e.html" title="New York Times">New York Times</a></i>, 2005-01-30. Retrieved on <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../j/u/l/July_8.html" title="July 8">07-08</a>. (in English)</li>
<li id="_note-lat">^ <a href="#_ref-lat_0" title=""><sup><i><b>a</b></i></sup></a> <a href="#_ref-lat_1" title=""><sup><i><b>b</b></i></sup></a> Romero, Dennis. "<a href="http://www.erowid.org/culture/characters/shulgin_alexander/shulgin_alexander_interview1.shtml" class="external text" title="http://www.erowid.org/culture/characters/shulgin_alexander/shulgin_alexander_interview1.shtml" rel="nofollow">Sasha Shulgin, Psychedelic Chemist</a>", <i><a href="../../../l/o/s/Los_Angeles_Times_ea99.html" title="Los Angeles Times">Los Angeles Times</a></i>, 1995-09-05. Retrieved on <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../j/u/l/July_8.html" title="July 8">07-08</a>. (in English)</li>
<li id="_note-0"><b><a href="#_ref-0" title="">^</a></b> <cite class="book" style="font-style:normal" id="Reference-Shulgin-1988"><strong class="selflink">Shulgin, Alexander</strong> (1988). <i>Controlled Substances: Chemical &amp; Legal Guide to Federal Drug Laws</i>. Ronin Publishing. <a href="../../../b/o/o/Special%7EBooksources_ed7b.html" class="internal">ISBN 0-914171-50-X</a>.</cite><span class="Z3988" title="ctx_ver=Z39.88-2004&amp;rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Abook&amp;rft.genre=book&amp;rft.btitle=Controlled+Substances%3A+Chemical+%26+Legal+Guide+to+Federal+Drug+Laws&amp;rft.title=Controlled+Substances%3A+Chemical+%26+Legal+Guide+to+Federal+Drug+Laws&amp;rft.aulast=Shulgin&amp;rft.aufirst=Alexander&amp;rft.date=1988&amp;rft.pub=Ronin+Publishing">&#160;</span></li>
<li id="_note-1"><b><a href="#_ref-1" title="">^</a></b> <a href="http://www.erowid.org/culture/characters/shulgin_alexander/shulgin_alexander_raid.shtml" class="external text" title="http://www.erowid.org/culture/characters/shulgin_alexander/shulgin_alexander_raid.shtml" rel="nofollow">DEA Raid of Shulgin's Laboratory</a>. <a href="../../../e/r/o/Erowid.html" title="Erowid">Erowid</a> (2004-01-08). Retrieved on <a href="../../../2/0/0/2006.html" title="2006">2006</a>-<a href="../../../j/u/l/July_8.html" title="July 8">07-08</a>.</li>
</ol>
</div>
<p><a name="External_links" id="External_links"></a></p>
<h2><span class="editsection">[<a href="../../../a/l/e/Alexander_Shulgin_ff31.html" title="Edit section: External links">edit</a>]</span> <span class="mw-headline">External links</span></h2>
<ul>
<li><a href="http://www.erowid.org/culture/characters/shulgin_alexander/" class="external text" title="http://www.erowid.org/culture/characters/shulgin_alexander/" rel="nofollow">Erowid Character Vaults&#160;: Alexander Shulgin</a></li>
<li><a href="http://www.cognitiveliberty.org/shulgin/blg/index.html" class="external text" title="http://www.cognitiveliberty.org/shulgin/blg/index.html" rel="nofollow">His 'Ask Dr. Shulgin' Blog</a></li>
<li><a href="http://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html" class="external text" title="http://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html" rel="nofollow">Dr. Ecstasy: a New York Times Magazine profile of Shulgin</a><a href="http://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html?ex=1264914000&amp;en=0b376d24e4f25bb5&amp;ei=5090&amp;partner=rssuserland" class="external text" title="http://www.nytimes.com/2005/01/30/magazine/30ECSTASY.html?ex=1264914000&amp;en=0b376d24e4f25bb5&amp;ei=5090&amp;partner=rssuserland" rel="nofollow">HTML-RSS version</a></li>
<li><a href="http://www.eastbayexpress.com/issues/2002-05-01/news/feature_full.html" class="external text" title="http://www.eastbayexpress.com/issues/2002-05-01/news/feature_full.html" rel="nofollow">2C-T-7's Bad Trip and Profile on Shulgin</a></li>
<li><a href="http://www.mdma.net/alexander-shulgin/index.html" class="external text" title="http://www.mdma.net/alexander-shulgin/index.html" rel="nofollow">Altered Statesman</a></li>
</ul>

<!-- 
Pre-expand include size: 13354 bytes
Post-expand include size: 4914 bytes
Template argument size: 3399 bytes
Maximum: 2048000 bytes
-->
<div class="printfooter">
Retrieved from "<a href="http://en.wikipedia.org../../../a/l/e/Alexander_Shulgin_ff31.html">http://en.wikipedia.org../../../a/l/e/Alexander_Shulgin_ff31.html</a>"</div>
	    <div id="catlinks"><p class='catlinks'><a href="../../../c/a/t/Special%7ECategories_101d.html" title="Special:Categories">Categories</a>: <span dir='ltr'><a href="../../../1/9/2/Category%7E1925_births.html" title="Category:1925 births">1925 births</a></span> | <span dir='ltr'><a href="../../../p/h/a/Category%7EPharmacologists_b22a.html" title="Category:Pharmacologists">Pharmacologists</a></span> | <span dir='ltr'><a href="../../../p/s/y/Category%7EPsychedelic_researchers_4752.html" title="Category:Psychedelic researchers">Psychedelic researchers</a></span> | <span dir='ltr'><a href="../../../l/i/v/Category%7ELiving_people_7259.html" title="Category:Living people">Living people</a></span> | <span dir='ltr'><a href="../../../p/s/y/Category%7EPsychedelic_advocates_and_proponents_27f9.html" title="Category:Psychedelic advocates and proponents">Psychedelic advocates and proponents</a></span></p></div>	    <!-- end content -->
	    <div class="visualClear"></div>
	  </div>
	</div>
      </div>
      <div id="column-one">
	<div id="p-cactions" class="portlet">
	  <h5>Views</h5>
	  <ul>
	    <li id="ca-nstab-main"
	       class="selected"	       ><a href="../../../a/l/e/Alexander_Shulgin_ff31.html">Article</a></li><li id="ca-talk"
	       	       ><a href="../../../a/l/e/Talk%7EAlexander_Shulgin_ca3d.html">Discussion</a></li><li id="ca-current"
	       	       ><a href="http://en.wikipedia.org/wiki/Alexander_Shulgin">Current revision</a></li>	  </ul>
	</div>
	<div class="portlet" id="p-logo">
	  <a style="background-image: url(../../../images/wiki-en.png);"
	    href="../../../index.html"
	    title="Main Page"></a>
	</div>
	<script type="text/javascript"> if (window.isMSIE55) fixalpha(); </script>
		<div class='portlet' id='p-navigation'>
	  <h5>Navigation</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-Main-page"><a href="../../../index.html">Main page</a></li>
	     	      <li id="n-Contents"><a href="../../../c/o/n/Wikipedia%7EContents_3181.html">Contents</a></li>
	     	      <li id="n-Featured-content"><a href="../../../f/e/a/Wikipedia%7EFeatured_content_24ba.html">Featured content</a></li>
	     	      <li id="n-currentevents"><a href="../../../c/u/r/Portal%7ECurrent_events_bb60.html">Current events</a></li>
	     	    </ul>
	  </div>
	</div>
		<div class='portlet' id='p-interaction'>
	  <h5>interaction</h5>
	  <div class='pBody'>
	    <ul>
	    	      <li id="n-About-Wikipedia"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html">About Wikipedia</a></li>
	     	      <li id="n-portal"><a href="../../../c/o/m/Wikipedia%7ECommunity_Portal_6a3c.html">Community portal</a></li>
	     	      <li id="n-contact"><a href="../../../c/o/n/Wikipedia%7EContact_us_afd6.html">Contact us</a></li>
	     	      <li id="n-sitesupport"><a href="http://wikimediafoundation.org/wiki/Fundraising">Make a donation</a></li>
	     	      <li id="n-help"><a href="../../../c/o/n/Help%7EContents_22de.html">Help</a></li>
	     	    </ul>
	  </div>
	</div>
		<div id="p-search" class="portlet">
	  <h5><label for="searchInput">Search</label></h5>
	  <div id="searchBody" class="pBody">
	    <form action="javascript:goToStatic(3)" id="searchform"><div>
	      <input id="searchInput" name="search" type="text"
	        accesskey="f" value="" />
	      <input type='submit' name="go" class="searchButton" id="searchGoButton"
	        value="Go" />
	    </div></form>
	  </div>
	</div>
	<div id="p-lang" class="portlet">
	  <h5>In other languages</h5>
	  <div class="pBody">
	    <ul>
	      	      <li>
	      <a href="../../../../de/a/l/e/Alexander_Shulgin_ff31.html">Deutsch</a>
	      </li>
	      	      <li>
	      <a href="../../../../fr/a/l/e/Alexander_Shulgin_ff31.html">Français</a>
	      </li>
	      	      <li>
	      <a href="../../../../nl/a/l/e/Alexander_Shulgin_ff31.html">Nederlands</a>
	      </li>
	      	      <li>
	      <a href="../../../../pl/a/l/e/Alexander_Shulgin_ff31.html">Polski</a>
	      </li>
	      	      <li>
	      <a href="../../../../ru/%D1%88/%D1%83/%D0%BB/%D0%A8%D1%83%D0%BB%D1%8C%D0%B3%D0%B8%D0%BD%2C_%D0%90%D0%BB%D0%B5%D0%BA%D1%81%D0%B0%D0%BD%D0%B4%D1%80_a206.html">Русский</a>
	      </li>
	      	      <li>
	      <a href="../../../../fi/a/l/e/Alexander_Shulgin_ff31.html">Suomi</a>
	      </li>
	      	      <li>
	      <a href="../../../../sv/a/l/e/Alexander_Shulgin_ff31.html">Svenska</a>
	      </li>
	      	    </ul>
	  </div>
	</div>
	      </div><!-- end of the left (by default at least) column -->
      <div class="visualClear"></div>
      <div id="footer">
    <div id="f-poweredbyico"><a href="http://www.mediawiki.org/"><img src="../../../skins/common/images/poweredby_mediawiki_88x31.png" alt="Powered by MediaWiki" /></a></div>	<div id="f-copyrightico"><a href="http://wikimediafoundation.org/"><img src="../../../images/wikimedia-button.png" border="0" alt="Wikimedia Foundation"/></a></div>	<ul id="f-list">
	  	  	  <li id="f-credits">This page was last modified 04:20, 26 March 2007 by Anonymous user(s) of Wikipedia. Based on work by Wikipedia user(s) <a href="../../../a/l/a/User%7EAlan_Rockefeller_4b2d.html" title="User:Alan Rockefeller">Alan Rockefeller</a>, Hvgap2, <a href="../../../u/s/e/User%7EUse_the_force_1aab.html" title="User:Use the force">Use the force</a>, <a href="../../../v/a/l/User%7EVald_d11b.html" title="User:Vald">Vald</a>, <a href="../../../t/h/i/User%7EThijs%21bot_bdf4.html" title="User:Thijs!bot">Thijs!bot</a>, <a href="../../../p/o/p/User%7EPopefauvexxiii_ab27.html" title="User:Popefauvexxiii">Popefauvexxiii</a>, <a href="../../../m/i/s/User%7EMiserlou_e394.html" title="User:Miserlou">Miserlou</a>, <a href="../../../s/0/u/User%7ES0uj1r0_a0cf.html" title="User:S0uj1r0">S0uj1r0</a>, Drautiola, <a href="../../../x/1/9/User%7EX1987x_57ab.html" title="User:X1987x">X1987x</a>, <a href="../../../z/a/m/User%7EZambaccian_0d80.html" title="User:Zambaccian">Zambaccian</a>, <a href="../../../s/i/n/User%7ESineWave_9632.html" title="User:SineWave">SineWave</a>, <a href="../../../s/m/a/User%7ESmackBot_cc7a.html" title="User:SmackBot">SmackBot</a>, <a href="../../../p/h/i/User%7EPhidauex_18a7.html" title="User:Phidauex">Phidauex</a>, <a href="../../../m/e/t/User%7EMetric_e945.html" title="User:Metric">Metric</a>, <a href="../../../r/u/s/User%7ERussBot_6f95.html" title="User:RussBot">RussBot</a>, <a href="../../../y/u/r/User%7EYurikBot_b393.html" title="User:YurikBot">YurikBot</a>, <a href="../../../b/o/b/User%7EBobby_P._Smith_Sr._Jr._bd1d.html" title="User:Bobby P. Smith Sr. Jr.">Bobby P. Smith Sr. Jr.</a>, <a href="../../../o/v/e/User%7EOverand_6955.html" title="User:Overand">Overand</a>, <a href="../../../e/b/a/User%7EEbacherdom_dd94.html" title="User:Ebacherdom">Ebacherdom</a>, <a href="../../../h/e/a/User%7EHeah_5965.html" title="User:Heah">Heah</a>, <a href="../../../z/o/e/User%7EZoe_6ab7.html" title="User:Zoe">Zoe</a>, <a href="../../../a/l/e/User%7EAlex_Bakharev_88ab.html" title="User:Alex Bakharev">Alex Bakharev</a>, <a href="../../../h/o/l/User%7EHolon67_7a0d.html" title="User:Holon67">Holon67</a>, <a href="../../../i/n/k/User%7EInkling_df45.html" title="User:Inkling">Inkling</a>, <a href="../../../g/h/o/User%7EGhosts%26empties_0e07.html" title="User:Ghosts&amp;empties">Ghosts&amp;empties</a>, <a href="../../../j/o/s/User%7EJoshi27_0f04.html" title="User:Joshi27">Joshi27</a>, Hammilton, <a href="../../../r/o/b/User%7ERobyWayne_5f41.html" title="User:RobyWayne">RobyWayne</a>, <a href="../../../a/x/e/User%7EAxelBoldt_4306.html" title="User:AxelBoldt">AxelBoldt</a>, <a href="../../../h/a/s/User%7EHasharBot_fdaa.html" title="User:HasharBot">HasharBot</a>, <a href="../../../c/l/e/User%7ECleduc_26ee.html" title="User:Cleduc">Cleduc</a>, <a href="../../../e/l/l/User%7EEllywa_5dd2.html" title="User:Ellywa">Ellywa</a>, <a href="../../../s/i/r/User%7ESir_Paul_8b76.html" title="User:Sir Paul">Sir Paul</a>, <a href="../../../l/u/n/User%7ELunaticFringe_0b7f.html" title="User:LunaticFringe">LunaticFringe</a>, <a href="../../../c/l/a/User%7EClarknova_c163.html" title="User:Clarknova">Clarknova</a>, <a href="../../../c/a/n/User%7ECanisRufus_0875.html" title="User:CanisRufus">CanisRufus</a>, <a href="../../../j/o/y/User%7EJoyous%21_8a6f.html" title="User:Joyous!">Joyous!</a>, <a href="../../../e/x/a/User%7EExabyte_953e.html" title="User:Exabyte">Exabyte</a>, <a href="../../../d/6/_/User%7ED6_9c90.html" title="User:D6">D6</a>, Arjuna, <a href="../../../g/a/d/User%7EGadfium_9104.html" title="User:Gadfium">Gadfium</a>, <a href="../../../t/r/i/User%7ETribble_d14c.html" title="User:Tribble">Tribble</a>, <a href="../../../c/u/r/User%7ECurps_5b50.html" title="User:Curps">Curps</a>, <a href="../../../e/e/q/User%7EEequor_b13d.html" title="User:Eequor">Eequor</a>, <a href="../../../a/h/o/User%7EAhoerstemeier_88c8.html" title="User:Ahoerstemeier">Ahoerstemeier</a>, <a href="../../../w/i/k/User%7EWik_19d3.html" title="User:Wik">Wik</a>, <a href="../../../p/r/e/User%7EPremeditated_Chaos_675b.html" title="User:Premeditated Chaos">Premeditated Chaos</a>, Mkaufman, <a href="../../../m/k/w/User%7EMkweise_6787.html" title="User:Mkweise">Mkweise</a>, <a href="../../../l/i/r/User%7ELir_4e26.html" title="User:Lir">Lir</a>, <a href="../../../g/a/b/User%7EGabbe_a391.html" title="User:Gabbe">Gabbe</a>, <a href="../../../t/h/e/User%7EThe_Anome_61a9.html" title="User:The Anome">The Anome</a>, <a href="../../../a/l/e/User%7EAlex_ca82.html" title="User:Alex">Alex</a>, <a href="../../../n/a/t/User%7ENate_Silva_5fc5.html" title="User:Nate Silva">Nate Silva</a>, <a href="../../../p/a/r/User%7EParallax_e0b2.html" title="User:Parallax">Parallax</a>, <a href="../../../o/r/t/User%7EOrtolan88_d8ce.html" title="User:Ortolan88">Ortolan88</a> and <a href="../../../0/_/_/User%7E0.html" title="User:0">0</a>.</li>	  <li id="f-copyright">All text is available under the terms of the <a class='internal' href="../../../t/e/x/Wikipedia%7EText_of_the_GNU_Free_Documentation_License_702a.html" title="Wikipedia:Text of the GNU Free Documentation License">GNU Free Documentation License</a>. (See <b><a class='internal' href="../../../c/o/p/Wikipedia%7ECopyrights_92c4.html" title="Wikipedia:Copyrights">Copyrights</a></b> for details.) <br /> Wikipedia&reg; is a registered trademark of the <a href="http://www.wikimediafoundation.org">Wikimedia Foundation, Inc</a>., a US-registered <a class='internal' href="../../../5/0/1/501%28c%29.html#501.28c.29.283.29" title="501(c)(3)">501(c)(3)</a> <a href="http://wikimediafoundation.org/wiki/Deductibility_of_donations">tax-deductible</a> <a class='internal' href="../../../n/o/n/Non-profit_organization.html" title="Non-profit organization">nonprofit</a> <a href="../../../c/h/a/Charitable_organization.html" title="Charitable organization">charity</a>.<br /></li>	  <li id="f-about"><a href="../../../a/b/o/Wikipedia%7EAbout_8d82.html" title="Wikipedia:About">About Wikipedia</a></li>	  <li id="f-disclaimer"><a href="../../../g/e/n/Wikipedia%7EGeneral_disclaimer_3e44.html" title="Wikipedia:General disclaimer">Disclaimers</a></li>	  	</ul>
      </div>
    </div>
  </body>
</html>
